Alina L.

Alina L. is an experienced Investor Relations Officer currently with Roche since January 2023. Prior experience includes serving as Director of Investor Relations at Novartis, where responsibilities encompassed managing partnerships, competitive intelligence, and strategic market analysis. Alina's career spans roles in equity research at Evercore and Cantor Fitzgerald, focusing on the medical devices and biotechnology sectors, along with experience in research at Memorial Sloan Kettering Cancer Center and the Max Planck Institute of Biochemistry. Alina holds a Ph.D. in Biomedical/Medical Engineering from ETH Zürich, along with a Master of Engineering from the same institution and a Bachelor of Engineering from The City College of New York. Additionally, Alina is currently pursuing coursework in Business Analytics and Financial Accounting at Harvard Business School.